Compare DealForma Alternatives

Companies are switching to DealForma for a reason.

Compare the DealForma features side by side.

Compare FeaturesSchedule Your Demo

 Finally, a deals database built specifically for biopharma.

DealForma stands out as the best in biopharma deal data with its comprehensive coverage of biotech and pharma licensing and funding transactions by providing a superior experience when it comes to deal terms. We focus on delivering high-quality deal data so you can have confidence that you are getting complete and accurate information for your biopharma business development deal comps and benchmark research.

DealForma vs Evaluate Pharma

DealForma vs. Evaluate Pharma

Evaluate Pharma specializes in consensus forecasts and market research. DealForma focuses specifically on biopharma deals and funding with granular and relevant categories to help with deal comps research and target partner assessment. DealForma offers an intuitive, modern interface with 100% analyst curated profiles, contracts, drug sales figures, and analyst support.

DealForma vs BioSciDB

DealForma vs. BioSciDB

BioSciDB specializes in deals with unredacted contracts and tagged contract provisions, offering valuable insights into the terms and conditions of agreements in the biopharma industry. DealForma excels in analyzing global deal and funding profiles with attached source documents providing you up-to-date information.  Additionally, DealForma offers you data on companies and drug sales figures all in a modern, powerful, and intuitive interface.

DealForma vs Clarivate Cortellis

DealForma vs. Clarivate Cortellis

Clarivate Cortellis focuses on company and clinical trial intelligence, providing comprehensive insights into businesses and their research activities. DealForma specializes in deal comps, upfronts, milestones, R&D, profit splits, deal structures, and asset stages, providing you valuable data for evaluating and comparing biopharma deals.

DealForma vs BioCentury BCIQ

DealForma vs. BioCentury BCIQ

BioCentury BCIQ is based on decades of editorial reporting keeping readers informed on industry developments since 1993. DealForma specializes in data-driven analyses of deals, funding, companies, investor profiles, and detailed product pipelines. The modern interface gives you the confidence knowing that you are working with highly-relevant data and powerful filters.

DealForma vs Biomedtracker

DealForma vs. Biomedtracker

Biomedtracker is renowned for its exceptional clinical development tracking and target analysis capabilities, providing users with comprehensive insights into the progress of clinical trials and target-specific information. DealForma specializes in contracts and license agreements, offering in-depth coverage of biopharma deal comps. DealForma also provides valuable information on private funding rounds, enabling you to stay updated on deal and funding activities in the industry.

DealForma vs Pitchbook

DealForma vs. PitchBook

PitchBook is widely recognized for its expertise in venture capital analysis and company-provided valuations across various industries. DealForma is focused on biopharma, so deal comps, therapeutic areas, modalities, discovery and clinical stages, and targets are intentionally curated to give you the most relevant data on biotech and pharma business development, licensing, and funding. DealForma is built for biopharma, from the data to the attached sources and contracts.

DealForma vs AlphaSense

DealForma vs. AlphaSense

AlphaSense specializes in Wall St. analyst reports and earnings call transcripts, providing valuable financial insights. DealForma excels in deal comps, upfronts, milestones, R&D, profit splits, deal structures, and asset stages, offering you analyst-curated and comprehensive data on biopharma deals.

DealForma Schedule Your Demo

Want to see for yourself?

Let’s have a screen-share demo to show what DealForma can do for you. Schedule your one-on-one demo.

Comprehensive Coverage

DealForma provides the most extensive coverage of biopharmaceutical transactions, including licensing deals, asset purchases, mergers, acquisitions, research partnerships, and funding rounds, ensuring you have access to a vast repository of relevant data.

In-Depth Analytics

With granular and relevant filters, DealForma allows you to delve into transaction details, track trends, and gain valuable insights into deal structures, valuations, therapeutic areas, and key players, enabling strategic planning, market analysis, and competitive intelligence.

Advanced Deal Monitoring

Business developers are switching to DealForma for its advanced deal monitoring capabilities. The platform enables you to set up alerts for specific criteria, such as target companies, indications, or modalities so you stay informed about the latest developments and deal opportunities.

Why are biopharma and finance companies switching to DealForma?

"DealForma is a Better Deal Database"

We keep hearing from business developers who have tried other databases and DealForma. They are switching to DealForma because of the deal-focused filters and the ability to quickly pull relevant deal comps knowing the content is high-quality. This saves them time when creating reports because the information is verified and up-to-date.

Intuitive, Modern Interface

You know that biopharma business development is full of complex terminology. But you shouldn’t have to remember how a database codes things. DealForma designed its platform from the ground up to make finding the most relevant information fast and easy. DealForma’s granular filters give you the confidence in working with the right data.

Intentional Biopharma Deal Curation

Analysts at DealForma have experience reading thousands of deal and funding announcements and company filings. Teams assigned to each segment look for key terms to separate out from a noisy news flow. And they do this manually, every day, so you can quickly filter through decades of carefully curated, relevant transaction profiles.

Included Analyst Support

DealForma goes beyond a mere database by providing you 20 hours of analyst time per year included with your subscription for you to leverage the expertise of skilled professionals to assist you in data interpretation, perform custom analyses, and provide valuable insights tailored to specific business needs.

{

The breadth and quality of information in DealForma has saved our team countless hours over other data sources. The focus on customers also sets them apart. Whether it’s a quick question or a custom project, we get the right people to talk to fast.

Sr. Director, Global Market Insights
Top 10 Pharma Company
{

I like DealForma’s comprehensive coverage of the life sciences industry. The intuitive search functions allow me to quickly extract deal benchmarks and other insights, which are useful in helping me evaluate potential opportunities.

Sal Macasieb, Jr.
Partner
Bellwether Analytics (previously)
{

DealForma is an exceptional and intuitive platform with reliable data that has saved us countless hours. The support team is quick to respond, and they go above and beyond to make sure we get what we need whether it is a quick question or a more intensive project.

Prakash Raman
Senior Partner, Chief BD Officer
Flagship Pioneering (previously)
{

Best product in the business!

Saira Ramasastry
Managing Partner
Life Sciences Advisory
{

I’ve been reviewing data on biopharma business trends for 16 years now, and no one does the number crunching better than Chris Dokomajilar at DealForma. I’ve seen the data pressure tested repeatedly, and it is solid. We’re proud to have him contribute regular pieces to Endpoints News.

John Carroll
Editor-in-Chief
Endpoints News
Genentech Roche Logo
JPMorgan Logo
Novartis Logo
Nimbus Logo

21,598

Licensing Deals

4,216

M&A

5,897

Other Deals

22,217

Funding Rounds

35,278

Company Profiles

27,588

Drug Sales Figures

All of this by stage, disease indication, modality, target...